| Item Type | Name |
|
Concept
|
Pregnancy
|
|
Concept
|
Pregnancy, Multiple
|
|
Concept
|
Pregnancy in Diabetics
|
|
Concept
|
Pregnancy Outcome
|
|
Concept
|
Pregnancy, Ectopic
|
|
Concept
|
Pregnancy Complications, Hematologic
|
|
Concept
|
Hypertension, Pregnancy-Induced
|
|
Concept
|
Pregnancy, High-Risk
|
|
Concept
|
Pregnancy Complications, Cardiovascular
|
|
Concept
|
Pregnancy Trimester, First
|
|
Concept
|
Pregnancy Trimester, Third
|
|
Concept
|
Pregnancy Complications
|
|
Concept
|
Pregnancy Complications, Infectious
|
|
Concept
|
Pregnancy, Twin
|
|
Concept
|
Pregnancy Proteins
|
|
Concept
|
Pregnancy Trimester, Second
|
|
Academic Article
|
Cytomegalovirus-induced mirror syndrome associated with elevated levels of circulating antiangiogenic factors.
|
|
Academic Article
|
Clinical characterization and outcomes of preeclampsia with normal angiogenic profile.
|
|
Academic Article
|
Fetal cheek-to-cheek diameter in the prediction of mode of delivery.
|
|
Academic Article
|
Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia.
|
|
Academic Article
|
Midpregnancy levels of angiogenic markers in relation to maternal characteristics.
|
|
Academic Article
|
Preeclampsia and the risk of large-for-gestational-age infants.
|
|
Academic Article
|
Subclinical left ventricular dysfunction in preeclamptic women with preserved left ventricular ejection fraction: a 2D speckle-tracking imaging study.
|
|
Academic Article
|
Placental expression of angiogenic factors in Trisomy 13.
|
|
Academic Article
|
Neuropsychological performance in normal pregnancy and preeclampsia.
|
|
Academic Article
|
Rupture of the posterior cul-de-sac during spontaneous labor.
|
|
Academic Article
|
Early-pregnancy soluble Fas levels in idiopathic small-for-gestational-age pregnancies.
|
|
Academic Article
|
Angiogenic factors in diagnosis, management, and research in preeclampsia.
|
|
Academic Article
|
Circulating soluble endoglin and placental abruption.
|
|
Academic Article
|
Cardiac angiogenic imbalance leads to peripartum cardiomyopathy.
|
|
Academic Article
|
Circulating Angiogenic Factors and the Risk of Adverse Outcomes among Haitian Women with Preeclampsia.
|
|
Academic Article
|
Ouabain inhibits placental sFlt1 production by repressing HSP27-dependent HIF-1a pathway.
|
|
Academic Article
|
Circulating lymphangiogenic factors in preeclampsia.
|
|
Academic Article
|
Epidemiology and Mechanisms of De Novo and Persistent Hypertension in the Postpartum Period.
|
|
Academic Article
|
Adverse maternal and fetal outcomes and deaths related to preeclampsia and eclampsia in Haiti.
|
|
Academic Article
|
Mid-pregnancy levels of angiogenic markers as indicators of pathways to preterm delivery.
|
|
Academic Article
|
Transcriptionally active syncytial aggregates in the maternal circulation may contribute to circulating soluble fms-like tyrosine kinase 1 in preeclampsia.
|
|
Academic Article
|
The course of angiogenic factors in early- vs. late-onset preeclampsia and HELLP syndrome.
|
|
Academic Article
|
The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes.
|
|
Academic Article
|
Plasma concentrations of soluble endoglin versus standard evaluation in patients with suspected preeclampsia.
|
|
Academic Article
|
Use of circulating antiangiogenic factors to differentiate other hypertensive disorders from preeclampsia in a pregnant woman on dialysis.
|
|
Academic Article
|
Relationship between nulliparity and preeclampsia may be explained by altered circulating soluble fms-like tyrosine kinase 1.
|
|
Academic Article
|
Role of oxidative stress and antioxidant supplementation in pregnancy disorders.
|
|
Academic Article
|
Response to Carbillon L et al. letter titled; "The imbalance of circulating angiogenic/anti-angiogenic factors is mild or absent in obese women destined to develop preeclampsia".
|
|
Academic Article
|
Circulating levels of the antiangiogenic marker soluble FMS-like tyrosine kinase 1 are elevated in women with pregestational diabetes and preeclampsia: angiogenic markers in preeclampsia and preexisting diabetes.
|
|
Academic Article
|
Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia.
|
|
Academic Article
|
First trimester vitamin D, vitamin D binding protein, and subsequent preeclampsia.
|
|
Academic Article
|
The use of angiogenic biomarkers to differentiate non-HELLP related thrombocytopenia from HELLP syndrome.
|
|
Academic Article
|
Angiogenic factors in preeclampsia: potential for diagnosis and treatment.
|
|
Academic Article
|
Angiogenic factors and pregnant woman with new onset seizures.
|
|
Academic Article
|
Preeclampsia: the role of angiogenic factors in its pathogenesis.
|
|
Academic Article
|
Circulating angiogenic factors and risk of adverse maternal and perinatal outcomes in twin pregnancies with suspected preeclampsia.
|
|
Academic Article
|
Placental origins of angiogenic dysfunction in mirror syndrome.
|
|
Academic Article
|
Management of abnormal serum markers in the absence of aneuploidy or neural tube defects.
|
|
Academic Article
|
Physicians' knowledge of future vascular disease in women with preeclampsia.
|
|
Academic Article
|
Modeling risk for severe adverse outcomes using angiogenic factor measurements in women with suspected preterm preeclampsia.
|
|
Academic Article
|
Placental lesions of vascular insufficiency are associated with anti-angiogenic state in women with preeclampsia.
|
|
Academic Article
|
Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia.
|
|
Academic Article
|
Angiogenic factors and renal disease in pregnancy.
|
|
Academic Article
|
Risk for developing gestational diabetes in women with twin pregnancies.
|
|
Academic Article
|
Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.
|
|
Academic Article
|
Relaxin-2 and Soluble Flt1 Levels in Peripartum Cardiomyopathy: Results of the Multicenter IPAC Study.
|
|
Academic Article
|
Circulating Antiangiogenic Factors and Myocardial Dysfunction in Hypertensive Disorders of Pregnancy.
|
|
Academic Article
|
Sequential plasma angiogenic factors levels in women with suspected preeclampsia.
|
|
Academic Article
|
KRYPTOR-automated angiogenic factor assays and risk of preeclampsia-related adverse outcomes.
|
|
Academic Article
|
The Impact of Magnesium Sulfate Therapy on Angiogenic Factors in Preeclampsia.
|
|
Academic Article
|
Intravital high-frequency ultrasonography to evaluate cardiovascular and uteroplacental blood flow in mouse pregnancy.
|
|
Academic Article
|
Racial Disparities in Comorbidities, Complications, and Maternal and Fetal Outcomes in Women With Preeclampsia/eclampsia.
|
|
Academic Article
|
Cardiogenic shock in pregnancy: Analysis from the National Inpatient Sample.
|
|
Academic Article
|
Gelsolin is an endogenous inhibitor of syncytiotrophoblast extracellular vesicle shedding in pregnancy.
|
|
Academic Article
|
Trophoblast mitochondrial function is impaired in preeclampsia and correlates negatively with the expression of soluble fms-like tyrosine kinase 1.
|
|
Academic Article
|
Increased Perinatal Morbidity and Mortality Among Asian American and Pacific Islander Women in the United States.
|
|
Academic Article
|
Angiogenic Proteins: Can These Biomarkers Help to Prevent Maternal Deaths Related to Preeclampsia?
|
|
Academic Article
|
Household air pollution and angiogenic factors in pregnant Nigerian women: A randomized controlled ethanol cookstove intervention.
|
|
Academic Article
|
Myocardial performance index in hypertensive disorders of pregnancy: The relationship between blood pressures and angiogenic factors.
|
|
Academic Article
|
Household air pollution and chronic hypoxia in the placenta of pregnant Nigerian women: A randomized controlled ethanol Cookstove intervention.
|
|
Academic Article
|
Prevalence, risk factors and associated complications of postpartum hypertension in rural Haiti.
|
|
Academic Article
|
Activin A and Late Postpartum Cardiac Dysfunction Among Women With Hypertensive Disorders of Pregnancy.
|
|
Academic Article
|
Abnormal mid-trimester cardiac strain in women with chronic hypertension predates superimposed preeclampsia.
|
|
Academic Article
|
Outcomes and mortality in parturient and non-parturient patients with peripartum cardiomyopathy: A national readmission database study.
|
|
Academic Article
|
Analytical validation of soluble fms-like tyrosine and placental growth factor assays on B·R·A·H·M·S KRYPTOR Compact Plus automated immunoassay platform.
|
|
Academic Article
|
Angiogenic biomarkers in triage and risk for preeclampsia with severe features.
|
|
Academic Article
|
Association of antepartum blood pressure levels and angiogenic profile among women with chronic hypertension.
|
|
Academic Article
|
Hypertensive Diseases of Pregnancy Increase Risk of Readmission With Heart Failure: A National Readmissions Database Study.
|
|
Academic Article
|
Angiogenic Factor Estimation as a Warning Sign of Preeclampsia-Related Peripartum Morbidity Among Hospitalized Patients.
|
|
Academic Article
|
Preeclampsia: Pathophysiology, Challenges, and Perspectives
|
|
Academic Article
|
Understanding and comparing practices of managing patients with hypertensive disorders of pregnancy in urban China and the United States.
|
|
Academic Article
|
Surgical Excision of a Left Atrial Myxoma During the Second Trimester of Pregnancy.
|
|
Academic Article
|
Severe antepartum hypertension and associated peripartum morbidity among pregnant women in an urban tertiary care medical center.
|
|
Academic Article
|
Effect of blood pressure control in early pregnancy and clinical outcomes in African American women with chronic hypertension.
|
|
Academic Article
|
Angiogenic factor abnormalities and risk of peripartum complications and prematurity among urban predominantly obese parturients with chronic hypertension.
|
|
Academic Article
|
Antepartum Aspirin Administration Reduces Activin A and Cardiac Global Longitudinal Strain in Preeclamptic Women.
|
|
Academic Article
|
Evaluation of angiogenic factors in the decision to admit women with suspected preeclampsia.
|
|
Academic Article
|
Derivation of endometrial gland organoids from term placenta.
|
|
Academic Article
|
Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders.
|
|
Academic Article
|
Luteolin-induced vasorelaxation in uterine arteries from normal pregnant rats.
|
|
Academic Article
|
Transcriptome and regulatory maps of decidua-derived stromal cells inform gene discovery in preterm birth.
|
|
Academic Article
|
Real life outpatient biomarker use in management of hypertensive pregnancies in third trimester in a low resource SeTting: ROBUST study.
|
|
Academic Article
|
Real-World Use of Biomarkers in Management of Hypertension During Pregnancy: Adjunct to Clinical Care.
|
|
Academic Article
|
Long-Term Postpartum Cardiac Function and Its Association With Preeclampsia.
|
|
Academic Article
|
Genetic and Phenotypic Landscape of Peripartum Cardiomyopathy.
|
|
Academic Article
|
Use of the angiogenic biomarker profile to risk stratify patients with fetal growth restriction.
|
|
Academic Article
|
The interval between births and the risk of recurrent preeclampsia among predominantly high risk women in urban tertiary care center.
|
|
Academic Article
|
Angiogenic factors and prediction for ischemic placental disease in future pregnancies.
|
|
Academic Article
|
Long-Term Cardiovascular Disease Risk in Women After Hypertensive Disorders of Pregnancy: Recent Advances in Hypertension.
|
|
Academic Article
|
Postpartum Outcomes With Systematic Treatment and Management of Postpartum Hypertension.
|
|
Academic Article
|
Is Prolonging Gestation in Preeclampsia For Better or Worse in Preventing Cardiovascular Disease?
|
|
Academic Article
|
Cost effectiveness of the sFlt1/PlGF ratio test as an adjunct to the current practice of evaluating suspected preeclampsia in the United States.
|
|
Academic Article
|
Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association.
|
|
Academic Article
|
Clinical interpretation and implementation of the sFlt-1/PlGF ratio in the prediction, diagnosis and management of preeclampsia.
|
|
Academic Article
|
Prevalence and management of severe intrapartum hypertension in patients with preeclampsia at an urban tertiary care medical center.
|
|
Academic Article
|
The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice.
|
|
Academic Article
|
Angiogenic Biomarkers for Risk Stratification in Women with Preeclampsia.
|
|
Academic Article
|
Elimination of racial disparities in postpartum hypertension follow-up after incorporation of telehealth into a quality bundle.
|
|
Academic Article
|
Racial Disparities in Diagnosis, Management, and Outcomes in Preeclampsia.
|
|
Academic Article
|
Women's perspectives and attitudes towards the utility of angiogenic biomarkers in preeclampsia.
|
|
Academic Article
|
Racial Differences in Readmissions in Hypertensive Disorders of Pregnancy.
|
|
Academic Article
|
Association of fetal sex with angiogenic factors in normotensive and hypertensive pregnancy states.
|
|
Academic Article
|
The additive role of angiogenic markers for women with confirmed preeclampsia.
|
|
Academic Article
|
A Comparison of Obstetric Interventions and Outcomes Between Black and White Patients at an Urban Tertiary Medical Center.
|
|
Grant
|
Angiogenic factors, abnormal placentation and adverse pregnancy outcomes
|
|
Grant
|
Luteolin as a therapeutic for hypertension in pregnancy
|
|
Academic Article
|
COVID-19 and obstetric outcomes: a single-center retrospective experience in a predominantly Black population.
|
|
Academic Article
|
Preeclampsia pathophysiology and adverse outcomes during pregnancy and postpartum.
|
|
Academic Article
|
Reducing the Risk of Term Preeclampsia by Risk-Stratified Timing of Birth: Time to Deliver.
|
|
Academic Article
|
Single cell profiling at the maternal-fetal interface reveals a deficiency of PD-L1+?non-immune cells in human spontaneous preterm labor.
|
|
Academic Article
|
Bioflavonoid luteolin prevents sFlt-1 release via HIF-1a inhibition in cultured human placenta.
|
|
Academic Article
|
Angiogenic Biomarkers for Preeclampsia in Clinical Setting: A New Era.
|
|
Academic Article
|
Patient and provider perception of home blood pressure monitoring kits.
|
|
Academic Article
|
Association of activin A and postpartum blood pressure in peripartum cardiomyopathy.
|
|
Academic Article
|
Luteolin prevents TNF-a-induced NF-?B activation and ROS production in cultured human placental explants and endothelial cells.
|
|
Academic Article
|
Circulating Angiogenic Factor Levels in Hypertensive Disorders of Pregnancy.
|
|
Academic Article
|
Signs or symptoms of suspected preeclampsia - A retrospective national database study of prevalence, costs, and outcomes.
|